Publications

Showing

0

out of

0

results

An update on cladribine for relapsing-remitting multiple sclerosis.

Holmoy T, Torkildsen O, Myhr KM.

December 31, 2016

Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study.

Bjornevik K, Riise T, Bostrom I,

December 31, 2016

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations.

Olafsson S, Stridh P, Bos SD,

December 31, 2016

Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study.

Nordin A, Akimoto C, Wuolikainen A,

December 31, 2016

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.

Holmoy T, Lindstrom JC, Eriksen EF,

December 31, 2016

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.

Logallo N, Novotny V, Assmus J,

December 31, 2016

Montreal Cognitive Assessment in a 63- to 65-year-old Norwegian Cohort from the General Population.

Ihle-Hansen H, Vigen T, Berge T,

December 31, 2016

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Rosjo E, Lossius A, Abdelmagid N,

December 31, 2016

The association between adolescent and parental use of non-prescription analgesics for headache and other somatic pain - A cross-sectional study.

Hasseleid SN, Clench-Aas J, Raanaas RK,

December 31, 2016

Antithrombotic treatment after stroke due to intracerebral haemorrhage.

Perry LA, Berge E, Bowditch J,

December 31, 2016